Objective-This study investigated the dominance of each limb of the autonomic nervous system and tested sympathetic-vagal interactions in the human ventricle and atrium after administration of propranolol and atropine. Patients and methods-The 90% monophasic action potential duration (MAPD90) and the effective refractory period (ERP) at the right ventricular apex (RV) and the right lateral atrium (RA) were measured in 14 patients. The MAPD90 was measured during constant RV and RA pacing (cycle length 600 ms) and the ERP was measured at a driven cycle length of 600 ms. Electrophysiological variables were measured during a control period, after propranolol (0 15 mg/kg loading dose followed by 0 1 mglmin infusion), and after autonomic blockade (atropine 0 04 mglkg). reported to be synergistic in the human atrium3 though their relative dominance in this part of the heart has not yet been fully defined. Furthermore, both limbs of the autonomic nervous system are known to interact with each other so that the vagal effect on cardiac electrophysiological properties becomes more pronounced as the level of resting sympathetic tone increases (sympathetic-vagal interaction). ' 4 In the present study we assessed the relative dominance of both limbs of the autonomic nervous system in terms of action potential duration and refractoriness in the human ventricle and atrium and investigated sympathetic-vagal interactions by using propranolol and atropine to produce pharmacological autonomic blockade.
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Patients and methods
We studied 14 
at a constant cycle length (CL) of 600 ms was performed for at least 3 min via the pacing bipole of the MAP catheter using 2 ms rectangular stimuli at twice diastolic threshold. MAP signals were simultaneously recorded with the same catheter. The RV MAP duration during constant RV pacing and the RA MAP duration during constant RA pacing were determined at 90% repolarisation (MAPD90) and averaged for at least three beats. Then RV and RA extrastimuli were delivered to the same sites through the same MAP catheter. A single extrastimulus (S2) was introduced in 5-10 ms steps after every eighth driven stimulus at a CL of 600 ms. The RV and RA effective refractory periods (ERPs) were defined as the longest RV and RA coupling intervals (S1S2) at which S2 did not achieve capture.
PROTOCOL
After the control electrophysiological variables were measured a loading dose of propranolol (0 15 mg/kg at 1 mg/min) was followed by continuous propranolol infusion at 0 1 mg/min. Electrophysiological data were obtained 5 min after infusion of the loading dose of propranolol. Then atropine (0 04 mg/kg) was infused for 5 min, and the electrophysiological data during autonomic blockade were measured 5 min after the atropine infusion.
STATISTICAL ANALYSIS
Results are mean (SD). Student (n = 14, p < 0 0005) and then increased slightly to 235(16) ms after autonomic blockade (n = 14, p = 0 07), so the overall effect of autonomic blockade was again to cause an increase from the control value (n = 14, p < 0 0005) ( fig 2B) . Mean arterial pressure during constant RA pacing (CL 600 ms) did not change between the control state, after propranolol, and after autonomic blockade (n = 14, 101(16) mm Hg v 101(17) mm Hg v 102(18) mm Hg). Figures 3 and 4 show a representative example of the effects of propranolol and autonomic blockade on the RV and RA MAPD90 (case 4).
Discussion EFFECTS OF THE AUTONOMIC NERVOUS SYSTEM ON THE HUMAN VENTRICLE
Sympathetic stimulation and adrenaline decreased the action potential duration (APD) and the ERP of the ventricle in both experimental8 9 and human studies.'0 Whereas in animal8I' and human studies in vivo"2 the ERP of the ventricle clearly increased in response to vagal stimulation or acetycholine (a vagal agonist). Thus it was suggested that vagal stimulation and sympathetic (fi) stimulation are antagonistic in the animal and human ventricle in vivo. In contrast, the effects of acetylcholine on the APD of the Purkinje fibres in different animal species in vitro varied widely."3 These differences in studies of vagal effects in vivo and in vitro have generally been explained on the basis of sympathetic-vagal interaction-that is, by accentuated vagal antagonism of sympathetic effects after an increase in sympathetic tone.' 49 However, Prystowsky et al suggested that vagal stimulation does not require a background sympathetic tone to exert its effect on the human ventricle, because atropine decreases the ERP of the ventricle even after preadministration of propranolol. In contrast, Morady et al suggested that a certain level of sympathetic tone was required for accentuated antagonism to occur in the human ventricle. '4 In the present study, propranolol significantly increased both the RV MAPD90 and the RV ERP, while the additional administration of atropine significantly decreased these variables to below the control values. These results accord with those of Prystowsky et al. We found that propranolol significantly increased both the RA MAPD90 and the RA ERP and that the addition of atropine further increased these variables. The difference between propranolol alone and autonomic blockade was not statistically significant, however. These results indicate that vagal stimulation and / stimulation are synergistic and that the effect of / stimulation predominates over that of direct vagal stimulation in the human atrium: we could not obtain total autonomic blockade in our patients because a stimulation was still present.
